Loading...
Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
BACKGROUND: Although established therapies are effective in most patients with generalized myasthenia gravis (gMG), some patients do not respond or they experience intolerable adverse events, highlighting the need for better tolerated, targeted therapies for treatment-refractory gMG. OBJECTIVE: To d...
Na minha lista:
| Udgivet i: | J Neuromuscul Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IOS Press
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8075396/ https://ncbi.nlm.nih.gov/pubmed/33325394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JND-200584 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|